Durham, NC 的 乳癌 臨床試驗
64 項針對 乳癌 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
招募中2 期歡迎健康志工
- University of North Carolina, Chapel Hill · 距離 10 英里
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
招募中2 期
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
招募中觀察性研究
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
招募中1 期
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
招募中觀察性研究歡迎健康志工
- University of North Carolina, Chapel Hill · 距離 10 英里
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
招募中2 期
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
招募中3 期
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- University of North Carolina Medical Center, Chapel Hill · 距離 10 英里
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
招募中2 期
- University of North Carolina Medical Center, Chapel Hill · 距離 10 英里
Identifying Patterns in the Breath of Individuals With Breast Cancer
招募中觀察性研究歡迎健康志工
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
招募中2 期
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距離 10 英里
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
招募中2 期
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 距離 10 英里
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
招募中觀察性研究
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
招募中1/2 期
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
招募中1/2 期
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
招募中3 期
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
招募中2 期
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
- University of North Carolina-Hillsborough Campus, Hillsborough · 距離 13 英里
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
招募中歡迎健康志工
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
Optimizing Surgical Decisions in Young Adults With Breast Cancer
招募中
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
招募中觀察性研究
- University of North Carolina, Chapel Hill · 距離 10 英里
Weight Management After Cancer for Survivors in Rural Communities
招募中
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
招募中
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
招募中2/3 期
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
招募中
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
招募中2 期
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
招募中
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
招募中1 期
- University of North Carolina, Chapel Hill · 距離 10 英里
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
招募中
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 距離 10 英里
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
招募中
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
招募中觀察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距離 10 英里
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
招募中3 期
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
招募中1 期
- University of North Carolina, Chapel Hill · 距離 10 英里
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
招募中2 期歡迎健康志工
- The University of North Carolina, Chapel Hill · 距離 10 英里
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
招募中觀察性研究
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
招募中
- University of North Carolina, Chapel Hill · 距離 10 英里
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
招募中2 期
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 距離 10 英里
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
招募中2 期
- The University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
招募中
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
招募中觀察性研究
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
招募中
- UNC Cancer Hospital, Chapel Hill · 距離 10 英里
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
招募中
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
招募中
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
招募中
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
BREAST Choice Decision Tool R21 - AIM2
招募中歡迎健康志工
- The University of North Carolina, Chapel Hill · 距離 10 英里
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
招募中
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距離 10 英里
UNC Pleural Fluid Registry
招募中觀察性研究
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
- San Antonio, TX47 項研究
Durham 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
- 胰臟癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。